The relationship between health-related quality of life (HRQoL) and clinical outcomes in patients with advanced renal cell carcinoma (aRCC) in CheckMate (CM) 214

In this interview, Prof. David Cella (US) talks about the CheckMate (CM) 214 study, which investigates the direct link between health-related quality of life (HRQoL) and clinical outcomes in advanced renal cell carcinoma patients.